Serum-Free Expanded Hair Follicle Mesenchymal Stem Cells Promote Cartilage Repair in a Murine Full-Thickness Defect Model.
This study indicates that hair follicle-derived mesenchymal stem cells can be expanded in serum-free conditions and may improve cartilage repair in a murine model, but further research is needed to confirm these findings in humans.
Where it sits
this study against the rest of the follistatin-344 corpusSummary and findings
The study evaluated the efficacy of serum-free expanded hair follicle mesenchymal stem cells (hfMSCs) in promoting cartilage repair in a murine model. Mice received intra-articular injections of 1 × 10⁵ hfMSCs or phosphate-buffered saline one week post-injury, with histological assessments conducted four weeks later. Results indicated improved cartilage repair scores with hfMSC treatment compared to controls.
Abstract
▒: Serum-free expanded hair follicle mesenchymal stem cells (hfMSCs) maintained mesenchymal phenotype and multipotency during static and stirred suspension bioreactor (SSB) expansion and promoted histological cartilage repair in a murine full-thickness cartilage defect model, with minimal direct engraftment yet expressing of a number of secreted protein (in vitro and in vivo), supporting a primarily paracrine mechanism of action.<h4>Background</h4>● Osteoarthritis is characterized by irreversible cartilage degeneration and limited intrinsic repair, and current treatments largely address symptoms rather than restoring cartilage structure. ● Mesenchymal stem cell therapies show promise for cartilage repair but are constrained by invasive tissue harvest, donor variability, and the need for scalable, serum-free biomanufacturing approaches.● hfMSCs obtained by minimally invasive hair plucking represent an accessible MSC source, but their performance after serum-free static and SSB expansion for cartilage repair has not been fully defined.<h4>Methods</h4>● hfMSCs from four adult donors were adapted from fetal bovine serum-containing media into a fully defined serum-free medium (PPRF-MSC-6) and expanded in either 2D static flasks or SSBs using Cultispher G microcarriers under serum-free conditions. ● Phenotype and potency were assessed by flow cytometry for canonical MSC markers and lack of hematopoietic markers, along with tri-lineage (osteogenic, adipogenic, chondrogenic) differentiation assays and quantitative mass spectrometry-based proteomics with pathway analysis. ● A NOD SCID murine full-thickness femoral groove cartilage defect model was used; one week post-injury, mice received intra-articular injections of 1 × 10⁵ hfMSCs (static- or SSB-expanded, male or female donor) or phosphate-buffered saline, followed by Safranin O-based histological scoring and immunofluorescent detection of human nuclear antigen and human SOX9 at four weeks post-injury.<h4>Results</h4>● Serum-free hfMSC expansion achieved robust proliferation in static culture (∼8-12-fold over 5 days) and comparable or greater proliferation in SSBs (∼15-fold in a representative donor), while preserving MSC surface marker expression and tri-lineage differentiation capacity across donors and culture formats.● Both static- and SSB-expanded hfMSCs significantly improved histological cartilage repair scores relative to phosphate-buffered saline controls, with regenerated tissue showing Safranin O-positive matrix, restoration of cartilage architecture, and integration with native cartilage. ● Human cell engraftment within the repair tissue was low with minimal SOX9 co-localization, and proteomic profiling revealed only modest differences between static and SSB conditions, with ZNF703 as the sole protein significantly upregulated. hfMSCs expressed a number of secreted proteins in vitro and in vivo including follistatin and α2-Macroglobulin.<h4>Conclusions</h4>● hfMSCs derived from plucked hair follicles can be expanded under fully defined serum-free conditions in either static flasks or SSBs while retaining mesenchymal phenotype, multipotency, and cartilage reparative function in vivo.● The comparable repair outcomes between static- and SSB-expanded cells, together with minimal proteomic alterations, indicate that scalable serum-free bioreactor processing can generate therapeutically competent hfMSCs suitable for translational cartilage repair applications.● Potential donor- and sex-associated variability in proliferation, engraftment patterns, and repair scores highlight the need for donor screening and standardized potency assays, and future studies in more chronic and immunocompetent models are warranted to define long-term efficacy and mechanistic contributions of hfMSC paracrine signaling.
Background
This paper addresses the challenge of cartilage repair in osteoarthritis, where current treatments do not restore cartilage structure. Mesenchymal stem cell (MSC) therapies have potential but face limitations such as invasive harvesting and donor variability. The study explores the use of hair follicle-derived MSCs, which can be obtained minimally invasively, and evaluates their performance in serum-free conditions for cartilage repair.
Methods
The study involved adapting hfMSCs from four adult donors into a serum-free medium and expanding them in static flasks or stirred suspension bioreactors. The primary outcome was histological cartilage repair assessed four weeks post-injury in a murine full-thickness cartilage defect model. hfMSCs were injected intra-articularly at a dose of 1 × 10⁵ cells.
Results
The primary endpoint showed significant improvement in histological cartilage repair scores compared to controls. The study reported robust proliferation of hfMSCs, with ∼8-12-fold in static culture and ∼15-fold in SSBs. Regenerated tissue exhibited Safranin O-positive matrix and integration with native cartilage.
Interpretation
The findings suggest that hfMSCs can be effectively expanded in serum-free conditions and retain their reparative functions. While the results are statistically significant, the clinical relevance may be limited due to the low level of human cell engraftment and the small sample size. The study's murine model may not fully represent human conditions, and further research is needed to validate these findings in more complex models.
Key findings
- ∼8-12-fold proliferation over 5 days in static culture, n=4 donors.
- ∼15-fold proliferation in stirred suspension bioreactors for a representative donor.
- Significant improvement in histological cartilage repair scores relative to phosphate-buffered saline controls.
- Low human cell engraftment with minimal SOX9 co-localization.
- ZNF703 was the sole protein significantly upregulated in proteomic profiling.
Limitations
- small n=4 donors
- murine model, not human data
- short follow-up of 4 weeks
- low human cell engraftment
- only one protein significantly upregulated